InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,002.80
(
0.50%
)
US TECH 100
20,571.60
(
0.15%
)
Dow Jones
44,070.31
(
0.78%
)
Brent Oil
73.92
(
-2.05%
)
Bitcoin
77,138.77
(
1.63%
)
Post# of 253560
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 75
Posts 4753
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Member Level

Re: ghmm post# 122715

Friday, 07/01/2011 8:34:59 PM

Friday, July 01, 2011 8:34:59 PM

Post# of 253560

what if one product (same mechanism) had better safety/tolerability or was more convenient[\quote]

If all they had in common was the same MOA then the drug with orphan status would have no more protection than if it had no orphan status. There may some slightly breadth of protection than patent protection but if all it has in common with the orphan drug than the only protection the orphan drug has is patent protection.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up